Physician profile
Josiah Carr
NPI 1255390795
$591.06
in general payments reported to CMS, 2019-2025
16 companies · $65.17 in 2025
The $65.17 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $124 · 2021: $103 · 2023: $104 · 2024: $69.35 · 2025: $65.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $136.54 | 2021-2024 | Vraylar |
| Novo Nordisk INC | $80.43 | 2019-2021 | |
| Abbott Laboratories | $59.64 | 2019-2025 | Freestyle Libre 3, Eterna |
| Takeda Pharmaceuticals U.S.A., INC. | $51.81 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $45.01 | 2020-2021 | |
| Astellas Pharma US INC | $42.28 | 2023-2024 | Veozah |
| Dexcom, INC. | $35.21 | 2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $28.80 | 2019-2020 | |
| Exact Sciences Corporation | $16.82 | 2023 | Cologuard Collection Kit |
| Dermira, INC. | $16.39 | 2020 | |
| Sonex Health, INC. | $15.42 | 2025 | Sx-One Microknife |
| Xeris Pharmaceuticals, INC. | $15.25 | 2023 | Keveyis |
| Esperion Therapeutics, INC. | $12.98 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $12.53 | 2019 | |
| Merck Sharp & Dohme LLC | $11.02 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josiah Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.